FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2567516909> ?p ?o ?g. }

• W2567516909 abstract "Abstract Isochromosome 17q [i(17q)], a poor prognostic cytogenetic abnormality is a product of the breakage or inappropriate division of the pericentromere leading to the duplication of the long and loss of the short arm of chromosome 17. The region of the breakpoints maps at 17p11, a region encompassing a key tumor suppressor gene: TP53. I(17q) are detected in myelodysplastic/ myeloproliferative neoplasms (MDS/ MPN), chronic myeloid leukemia (CML), and acute myeloid leukemia (AML). This abnormality can occur as a sole structural abnormality or in combination with other chromosomal defects. The presence of i(17q) is associated with poor therapeutic response, disease progression, and an unfavorable clinical outcome. Elucidation of the molecular architecture of patients (pts) carrying i(17q) may lead to better understanding of disease biology and development of novel compounds that can target this disease. We selected 11 pts with i(17q) to characterize their genomic differences. We applied whole exome sequencing (WES) in order to define latent molecular defects explaining the clinical phenotype of this disease. The index case was a male MDS/MPN pt with isolated i(17q), 27% RS, hypercellular bone marrow (BM), mild splenomegaly, and atypical megakaryocytes. The pt developed 7% BM blasts without clinical response to growth factors. Molecularly this pt was a wild type SF3B1, a gene frequently mutated in RARS-T and associated with lower transformation rate to leukemia, better survival, and good/intermediate risk cytogenetic abnormalities. WES was performed on 2 ug of total DNA extracted from BM cells. Non-clonal CD3+ cells were used as source of germ-line control. Twenty-millions reads were run on an Illumina HiSeq2000 sequencer. Using a stringent bio-informatic algorithm developed in house, all variants were filtered based on a variation score (>=30) and a coverage (30X) and the tumor nucleotide variation analysis was performed for each pair (tumor vs. germ-line), where only the variants unique to the tumor were retained. Variants were ultimately filtered in order to exclude SNPs by an in-house annotation and importing the hg19 SNP135. We detected 65 unique candidate genes. Four genes were confirmed to be somatic: 3 were novel: ZFP42 (4q35.2), P4HTM (3p21.31), and VPRBP (3p21.2) and 1 includes the newly discovered SETBP1 (18q12.3) gene. Three variants detected on the chromosome 17 had a wild type configuration. The subsequently genotyped all the pts (MDS/MPN/-U 3; AML 4; RCMD 1; CML 1; RAEB-1 2; mean age: 68 years; male/female: 8/3; i(17q)/other abnormalities:3/8) for the above genes and for a panel of genes known to be mutated in MDS/MPN and other diseases in order to find any genetic association explaining the disase phenotype. We applied Sanger sequencing to DNA derived from BM/peripheral blood cells (BM/PB:7/4) for the following genes and respective exons: TP53 (all exons), SF3B1 (13-16), SRSF2 (1-2), U2AF1 (2 and 6), TET2 (all exons), DNMT3A (18-23), IDH1/2 (4), CBL (8-9), N/KRAS (1-2), ASXL1 (12), JAK2 (12 and 14), EZH2 (16, 18 and 19), MPL (exon 10), BCAS3 (12, 15 and 16), FLT3 (11 and 17), and CSF3R (13,14, and 17). In total, we found 16 heterozygous missense mutations and 1 tandem duplication. We found somatic mutations in ZFP42, P4HTM, and VPRBP in 1 pt. The index case reported a mutation in SETBP1 and SRSF2. SF3B1 was detected as a sole abnormality in 1 patient. Of note, the patient with SF3B1 mutation (K700E) had 50% RS and achieved a complete hematologic remission after decitabine therapy. The most frequent mutations were found in SETBP1 and SRSF2. SETBP1 was found to be mutated in 4/11 (36.3%) pts (D868N, I871T, and G870S was common in 2 pts) while SRSF2 mutations (P95H/R) were found in 3/11 (27.2%) pts. Three pts showed concomitant SRSF2 and SETBP1 mutations. NRAS (G12D) was mutated in 1 pt and associated with SRSF2 and SETBP1 mutations. One pt showed mutations in TET2, JAK2, and TP53. Of note, this pt did not respond to treatment. One pt with MDS/MPN showed a mutation in CSF3R (Q741X), a novel gene discovered in chronic neutrophilic leukemia and atypical CML. The pt also has monosomy 7 and i(17q) abnormality. FLT3-ITD was found in 1 pt. As of last follow-up, only 2 pts remain alive. In sum, we found that poor risk molecular mutations in SRSF2 and SETBP1 are frequently found in i(17q) myeloid malignancies and may be the drivers of poor outcomes in this disease. Disclosures: No relevant conflicts of interest to declare." @default.
• W2567516909 created "2017-01-06" @default.
• W2567516909 creator A5008949414 @default.
• W2567516909 creator A5011922168 @default.
• W2567516909 creator A5012152705 @default.
• W2567516909 creator A5016847107 @default.
• W2567516909 creator A5025468259 @default.
• W2567516909 creator A5026244195 @default.
• W2567516909 creator A5027080346 @default.
• W2567516909 creator A5042759699 @default.
• W2567516909 creator A5049987484 @default.
• W2567516909 creator A5055740968 @default.
• W2567516909 creator A5066716873 @default.
• W2567516909 creator A5067223918 @default.
• W2567516909 creator A5075839840 @default.
• W2567516909 creator A5077292257 @default.
• W2567516909 creator A5082944296 @default.
• W2567516909 date "2013-11-15" @default.
• W2567516909 modified "2023-09-28" @default.
• W2567516909 title "Molecular Characterization Of Myeloid Neoplasms Harboring Isochromosome 17q Abnormality" @default.
• W2567516909 doi "https://doi.org/10.1182/blood.v122.21.2596.2596" @default.
• W2567516909 hasPublicationYear "2013" @default.
• W2567516909 type Work @default.
• W2567516909 sameAs 2567516909 @default.
• W2567516909 citedByCount "1" @default.
• W2567516909 countsByYear W25675169092014 @default.
• W2567516909 crossrefType "journal-article" @default.
• W2567516909 hasAuthorship W2567516909A5008949414 @default.
• W2567516909 hasAuthorship W2567516909A5011922168 @default.
• W2567516909 hasAuthorship W2567516909A5012152705 @default.
• W2567516909 hasAuthorship W2567516909A5016847107 @default.
• W2567516909 hasAuthorship W2567516909A5025468259 @default.
• W2567516909 hasAuthorship W2567516909A5026244195 @default.
• W2567516909 hasAuthorship W2567516909A5027080346 @default.
• W2567516909 hasAuthorship W2567516909A5042759699 @default.
• W2567516909 hasAuthorship W2567516909A5049987484 @default.
• W2567516909 hasAuthorship W2567516909A5055740968 @default.
• W2567516909 hasAuthorship W2567516909A5066716873 @default.
• W2567516909 hasAuthorship W2567516909A5067223918 @default.
• W2567516909 hasAuthorship W2567516909A5075839840 @default.
• W2567516909 hasAuthorship W2567516909A5077292257 @default.
• W2567516909 hasAuthorship W2567516909A5082944296 @default.
• W2567516909 hasConcept C104317684 @default.
• W2567516909 hasConcept C2778461978 @default.
• W2567516909 hasConcept C2778729363 @default.
• W2567516909 hasConcept C2779282312 @default.
• W2567516909 hasConcept C2780189214 @default.
• W2567516909 hasConcept C30481170 @default.
• W2567516909 hasConcept C502942594 @default.
• W2567516909 hasConcept C53226629 @default.
• W2567516909 hasConcept C54355233 @default.
• W2567516909 hasConcept C57269778 @default.
• W2567516909 hasConcept C86803240 @default.
• W2567516909 hasConceptScore W2567516909C104317684 @default.
• W2567516909 hasConceptScore W2567516909C2778461978 @default.
• W2567516909 hasConceptScore W2567516909C2778729363 @default.
• W2567516909 hasConceptScore W2567516909C2779282312 @default.
• W2567516909 hasConceptScore W2567516909C2780189214 @default.
• W2567516909 hasConceptScore W2567516909C30481170 @default.
• W2567516909 hasConceptScore W2567516909C502942594 @default.
• W2567516909 hasConceptScore W2567516909C53226629 @default.
• W2567516909 hasConceptScore W2567516909C54355233 @default.
• W2567516909 hasConceptScore W2567516909C57269778 @default.
• W2567516909 hasConceptScore W2567516909C86803240 @default.
• W2567516909 hasLocation W25675169091 @default.
• W2567516909 hasOpenAccess W2567516909 @default.
• W2567516909 hasPrimaryLocation W25675169091 @default.
• W2567516909 hasRelatedWork W2039206099 @default.
• W2567516909 hasRelatedWork W2258552642 @default.
• W2567516909 hasRelatedWork W2394487571 @default.
• W2567516909 hasRelatedWork W2538799886 @default.
• W2567516909 hasRelatedWork W2550084043 @default.
• W2567516909 hasRelatedWork W2550632421 @default.
• W2567516909 hasRelatedWork W2550786827 @default.
• W2567516909 hasRelatedWork W2575453587 @default.
• W2567516909 hasRelatedWork W2589796005 @default.
• W2567516909 hasRelatedWork W2610522331 @default.
• W2567516909 hasRelatedWork W2734556695 @default.
• W2567516909 hasRelatedWork W2735041721 @default.
• W2567516909 hasRelatedWork W2908224544 @default.
• W2567516909 hasRelatedWork W2939957619 @default.
• W2567516909 hasRelatedWork W2979603455 @default.
• W2567516909 hasRelatedWork W2979921102 @default.
• W2567516909 hasRelatedWork W2980066808 @default.
• W2567516909 hasRelatedWork W2980092802 @default.
• W2567516909 hasRelatedWork W3047681891 @default.
• W2567516909 hasRelatedWork W2899785076 @default.
• W2567516909 isParatext "false" @default.
• W2567516909 isRetracted "false" @default.
• W2567516909 magId "2567516909" @default.
• W2567516909 workType "article" @default.